Published in J Infect Dis on March 02, 2004
Molecular identification of mumps virus genotypes from clinical samples: standardized method of analysis. J Clin Microbiol (2005) 1.15
Detection of RNA of mumps virus during an outbreak in a population with a high level of measles, mumps, and rubella vaccine coverage. J Clin Microbiol (2008) 1.02
Characterization of mumps viruses circulating in Mongolia: identification of a novel cluster of genotype H. J Clin Microbiol (2011) 0.88
Molecular epidemiological evaluation of the recent resurgence in mumps virus infections in Ireland. J Clin Microbiol (2010) 0.86
Enzyme-linked immunospot assay detection of mumps-specific antibody-secreting B cells as an alternative method of laboratory diagnosis. Clin Vaccine Immunol (2010) 0.83
A 176 amino acid polypeptide derived from the mumps virus HN ectodomain shows immunological and biological properties similar to the HN protein. Virol J (2010) 0.81
Viral etiology of mumps-like illnesses in suspected mumps cases reported in Catalonia, Spain. Hum Vaccin Immunother (2014) 0.78
Genetic variation in the HN and SH genes of mumps viruses: a comparison of strains from mumps cases with and without neurological symptoms. PLoS One (2013) 0.77
Circulation of mumps virus genotypes in Spain from 1996 to 2007. J Clin Microbiol (2010) 0.77
Application of Oral Fluid Assays in Support of Mumps, Rubella and Varicella Control Programs. Vaccines (Basel) (2015) 0.75
Population-based study of antibody to the human polyomaviruses BKV and JCV and the simian polyomavirus SV40. J Med Virol (2003) 3.73
Performance of commercially available enzyme immunoassays for detection of antibodies against herpes simplex virus type 2 in African populations. J Clin Microbiol (2004) 2.55
Clinical manifestation of norovirus gastroenteritis in health care settings. Clin Infect Dis (2004) 2.50
Two epidemiologic patterns of norovirus outbreaks: surveillance in England and wales, 1992-2000. Emerg Infect Dis (2003) 2.50
Viral encephalitis in England, 1989-1998: what did we miss? Emerg Infect Dis (2003) 2.26
Protective effect of natural rotavirus infection in an Indian birth cohort. N Engl J Med (2011) 2.04
The effectiveness of the mumps component of the MMR vaccine: a case control study. Vaccine (2005) 1.80
Vaccine effectiveness estimates, 2004-2005 mumps outbreak, England. Emerg Infect Dis (2007) 1.79
Diversity of noroviruses cocirculating in the north of England from 1998 to 2001. J Clin Microbiol (2004) 1.65
Neonatal measles immunity in rural Kenya: the influence of HIV and placental malaria infections on placental transfer of antibodies and levels of antibody in maternal and cord serum samples. J Infect Dis (2005) 1.56
A summertime peak of "winter vomiting disease": surveillance of noroviruses in England and Wales, 1995 to 2002. BMC Public Health (2003) 1.53
Diphtheria in the postepidemic period, Europe, 2000-2009. Emerg Infect Dis (2012) 1.49
Association of genital shedding of herpes simplex virus type 2 and HIV-1 among sex workers in rural Zimbabwe. AIDS (2006) 1.27
School based HIV prevention in Zimbabwe: feasibility and acceptability of evaluation trials using biological outcomes. AIDS (2002) 1.18
Is sexual contact with sex workers important in driving the HIV epidemic among men in rural Zimbabwe? J Acquir Immune Defic Syndr (2005) 1.11
High genetic diversity of measles virus, World Health Organization European Region, 2005-2006. Emerg Infect Dis (2008) 1.11
Molecular epidemiology of rotaviral infection in South Indian children with acute diarrhea from 1995-1996 to 1998-1999. J Med Virol (2002) 1.10
Multiplexed immunoassays by flow cytometry for diagnosis and surveillance of infectious diseases in resource-poor settings. Lancet Infect Dis (2002) 1.09
The appropriateness of core group interventions using presumptive periodic treatment among rural Zimbabwean women who exchange sex for gifts or money. J Acquir Immune Defic Syndr (2005) 1.05
Immunity to tetanus and diphtheria in the UK in 2009. Vaccine (2012) 1.05
Tetanus in injecting drug users, United Kingdom. Emerg Infect Dis (2006) 1.03
Increased positive selection pressure in persistent (SSPE) versus acute measles virus infections. J Gen Virol (2002) 1.02
Genetic variability of measles virus in acute and persistent infections. Infect Genet Evol (2005) 1.02
Sero-epidemiological patterns of Epstein-Barr and herpes simplex (HSV-1 and HSV-2) viruses in England and Wales. J Med Virol (2002) 0.95
Development of a focus reduction neutralization test (FRNT) for detection of mumps virus neutralizing antibodies. J Virol Methods (2009) 0.94
Infections with spore-forming bacteria in persons who inject drugs, 2000-2009. Emerg Infect Dis (2013) 0.93
Characterisation of norovirus strains in rural Ghanaian children with acute diarrhoea. J Med Virol (2006) 0.92
Methods for the detection and characterisation of noroviruses associated with outbreaks of gastroenteritis: outbreaks occurring in the north-west of England during two norovirus seasons. J Med Virol (2004) 0.91
Evaluation of a measles vaccine campaign in Ethiopia using oral-fluid antibody surveys. Vaccine (2008) 0.91
Prevalence of eye signs in congenital rubella syndrome in South India: a role for population screening. Br J Ophthalmol (2007) 0.90
Laboratory confirmation of congenital rubella syndrome in infants: an eye hospital based investigation. J Med Virol (2008) 0.89
The burden of infection with herpes simplex virus type 1 and type 2: seroprevalence study in Estonia. Scand J Infect Dis (2004) 0.87
Development and evaluation of a real-time PCR assay for rapid identification and semi-quantitation of measles virus. J Med Virol (2007) 0.87
Childhood vaccination coverage by ethnicity within London between 2006/2007 and 2010/2011. Arch Dis Child (2013) 0.87
The contribution of single antigen measles, mumps and rubella vaccines to immunity to these infections in England and Wales. Arch Dis Child (2007) 0.86
Comparison of fifteen commercial assays for detecting Varicella Zoster virus IgG with reference to a time resolved fluorescence immunoassay (TRFIA) and the performance of two commercial assays for screening sera from immunocompromised individuals. J Virol Methods (2008) 0.85
Measles mortality reduction in Africa. Lancet (2009) 0.84
Expression and antigenic characterization of the major capsid proteins of human polyomaviruses BK and JC in Saccharomyces cerevisiae. J Virol Methods (2002) 0.83
Screening and toxigenic corynebacteria spread. Emerg Infect Dis (2006) 0.81
Cervicovaginal neutralizing antibodies to herpes simplex virus (HSV) in women seropositive for HSV Types 1 and 2. Clin Diagn Lab Immunol (2003) 0.77
Genetic variation in the HN and SH genes of mumps viruses: a comparison of strains from mumps cases with and without neurological symptoms. PLoS One (2013) 0.77
Application of the heteroduplex mobility assay (HMA) for the investigation of the genomic diversity among noroviruses in environmental samples. J Virol Methods (2004) 0.75